New Trends in Diabetes Treatment: New Antidiabetic Medications Provide Enhanced Cardiovascular and Cerebrovascular Protection
Diabetes patients who also have high blood pressure and high cholesterol are at a higher risk of developing cardiovascular diseases and leading to various complications, such as coronary heart disease, myocardial infarction, stroke and kidney failure, etc. Dr Ng Kei-yan Andrew, Consultant in Cardiology at Gleneagles Hospital Hong Kong, points out that diabetes patients have up to three times higher risk of cardiovascular diseases compared to healthy person asthey are more likely to have their blood vessels narrowed and blocked. If patients fail to manage their condition properly, there is an increased risk of failure in various organs and even an increased mortality risk.
New Treatment Approach: From "Blood Sugar Control" to "Organ Protection"
Previously, Dr Ng and a team of specialists conducted a joint study to compare the effectiveness of diabetes medications, analysing data from more than 20,000 diabetes patients with an average age of 59, comparing the three-year efficacy of intaking the new type of antidiabetic medicine "SGLT-2 inhibitors" versus "DPP-4 inhibitors". The results showed that, compared to "DPP-4 inhibitors", "SGLT-2 inhibitors" are more effective in reducing the risk of cardiovascular and cerebrovascular diseases in diabetic patients. By eliminating glucose and salt through urine, "SGLT-2 inhibitors" reduce the risk of related diseases, such as kidney failure, etc.
Treatment and Daily Management
Beyond medication, patients should monitor blood sugar regularly, maintain a balance diet, do exercise regularly and undergo annual electrocardiograms. High-risk individuals may require further assessments according to doctor's advice, such as heart CT scan, ultrasound, treadmill test, etc. If you have any concerns about your condition, please seek medical advice as soon as possible. Patients should discuss the most suitable personalised treatment option with their doctors. 🔎Please click here to read the article (in Chinese only) where Dr Ng Kei-yan Andrew explains more on diabetes and the latest treatment trends.
糖尿病治療新趨勢：新型降血糖藥物保護心腦血管 療效更佳
糖尿病患者若同時患有高血壓、高膽固醇等問題，有較高機會誘發心血管疾病及出現多種併發症，如冠心病、心肌梗塞、中風、腎衰竭等。港怡醫院心臟科顧問醫生吳基恩醫生指出，糖尿病患者的心血管會較易收窄及閉塞，因此罹患心血管疾病的風險較常人高達三倍。假如患者未能好好控制病情，會容易出現不同器官衰竭的風險，甚至增加死亡風險。
治療新方向：從「控糖」到「護器官」
早前，吳醫生聯同多名專科醫生進行了一項聯合研究，目的是比較糖尿病藥物的成效，分析了2萬多名平均年齡為59歲的糖尿病患者，評估患者分別服用兩種較新糖尿病藥物「SGLT-2抑制劑」及「DPP-4抑制劑」後的心血管疾病風險，追蹤期接近3年。結果顯示，相對於「DPP-4抑制劑」，「SGLT-2抑制劑」更能減低糖尿病患者患上心腦血管疾病等風險。此藥物可讓患者透過尿液排走糖分和鹽分，從而對心腦血管產生保護，減低患上相關疾病、腎衰竭等風險。
治療與日常管理
除了藥物治療，患者應定期監測血糖、控制飲食及進行適量運動，並每年進行心電圖檢查。而高風險患者可根據醫生建議作進一步的檢查，如心臟掃描、超聲波檢查或運動心電圖等。一旦懷疑出現併發症，應儘快求醫及接受適當診治。糖尿病治療方案需因人而異，患者應與醫生商討最合適的選擇。 🔎請按此閱讀文章，由吳基恩醫生解說有關糖尿病與治療的新趨勢。 | 
No comments:
Post a Comment